The Clinical Exome Trio Sequencing Test is a comprehensive genetic screening process designed to identify the genetic causes of inherited diseases within a family. Conducted at DNA Labs UAE, this advanced diagnostic test involves sequencing the exomes—the parts of the genome that encode proteins—of three individuals, typically the child and both parents. This trio approach significantly enhances the ability to pinpoint disease-causing mutations by comparing the child’s genetic information with that of the parents, thereby offering insights into the inheritance patterns and potential genetic disorders.

The test is particularly useful in cases where a child presents with symptoms of a genetic disorder that has not been diagnosed through other means. It can identify mutations in over 20,000 genes, covering a vast array of inherited conditions, including rare diseases that may not be detected through standard genetic tests. The Clinical Exome Trio Sequencing Test is invaluable for families seeking answers to complex genetic health puzzles, offering a pathway to targeted treatment options and personalized medical care.

The cost of the Clinical Exome Trio Sequencing Test at DNA Labs UAE is 12,000 AED. This investment covers the comprehensive analysis and detailed reporting necessary to understand the genetic underpinnings of inherited conditions, making it a critical step for families in pursuit of diagnosis, informed decision-making, and management of genetic disorders.